Author Details

Kolyadina, Irina

Issue Section Title File
Vol 15, No 3 (2013) Articles Prognosticheskoe znachenie lokal'nogo i sistemnogo lecheniya pri rake molochnoy zhelezy I stadii
Vol 21, No 2 (2019) Articles The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience PDF
(Rus)
Vol 21, No 1 (2019) Articles Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia PDF
(Rus)
Vol 21, No 1 (2019) Articles The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review) PDF
(Rus)
Vol 21, No 3 (2019) Articles Complex radiologic imaging of early breast cancer (literature review) PDF
(Rus)
Vol 21, No 3 (2019) Articles The predictive value of digital mammography, breast ultrasound and their combination in the diagnosis of early breast cancer PDF
(Rus)
Vol 21, No 3 (2019) Articles The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer PDF
(Rus)
Vol 22, No 1 (2020) CLINICAL ONCOLOGY Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer PDF
(Rus)
Vol 22, No 2 (2020) Best Practice Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience PDF
(Rus) PDF
(Eng)
Vol 23, No 1 (2021) CLINICAL ONCOLOGY Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice PDF
(Rus) PDF
(Eng)
Vol 23, No 1 (2021) CLINICAL ONCOLOGY Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer PDF
(Rus)
Vol 23, No 2 (2021) CLINICAL ONCOLOGY Biological features of ductal carcinoma in situ: clinical role and basis for treatment individualization PDF
(Rus)
Vol 23, No 4 (2021) CLINICAL ONCOLOGY Features of response to modern neoadjuvant chemotherapy with dual anti-HER2 blockade (trastuzumab and pertuzumab) in the patients with HER2-positive breast cancer stage II–III PDF
(Rus)
Vol 25, No 1 (2023) CLINICAL ONCOLOGY Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review PDF
(Rus)
Vol 25, No 1 (2023) CLINICAL ONCOLOGY Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review PDF
(Rus)
Vol 25, No 2 (2023) CLINICAL ONCOLOGY Hydroxyethyldimethyldihydropyrimidine as the drug of choice for the prevention of paraprosthetic seromas in breast reconstructive surgery: A retrospective study PDF
(Rus)
Vol 25, No 4 (2023) CLINICAL ONCOLOGY The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast PDF
(Rus)
Vol 26, No 1 (2024) Articles Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review PDF
(Rus)
Vol 26, No 1 (2024) Articles Efficacy and safety of alpelisib in patients with HR+HER2-negative metastatic breast cancer in real clinical practice: Results of a single-center observational retrospective study PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies